Intellipharmaceutics: Fiscal Q2 Earnings Snapshot
By AP News
Published - Jul 14, 2023, 04:18 PM ET
Last Updated - Jul 14, 2023, 04:18 PM EDT
TORONTO (AP) — TORONTO (AP) — Intellipharmaceutics International Inc. (IPCIF) on Friday reported a loss of $54,000 in its fiscal second quarter.
The Toronto-based company said it had a loss of less than 1 cent on a per-share basis.
The extended-release drug developer posted revenue of $480,200 in the period. Its adjusted revenue was $480,000.
_____
